This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Fastenal's October Daily Sales Increase 2.8%, Stock Up
by Zacks Equity Research
FAST's average daily sales growth rate moderated sequentially in October, with improving heavy manufacturing end markets though declines in non-residential markets returned.
Vital Farms (VITL) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 14.29% and 0.21%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Clorox Stock Gains 3.8% in a Week on Solid Q1 Results: Buy or Avoid?
by Zacks Equity Research
CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
B&G Foods Cuts View on Q3 Earnings Miss, Soft Consumption Trends
by Zacks Equity Research
BGS Q3 results are impacted by lower unit volumes and the Green Giant U.S. shelf-stable divestiture, partly offset by better net pricing and product mix.
Grocery Outlet Q3 Earnings & Sales Beat Estimates, Comps Jump 1.2%
by Zacks Equity Research
GO reports Q3 2024 results with a 10.4% net sales increase, driven by solid comparable store sales performance and the addition of new store openings.
Archer Daniels Reports Preliminary Q3 Results, Trims 2024 EPS Outlook
by Zacks Equity Research
ADM announces preliminary results for the third quarter of 2024. The Nutrition business witnesses lower-than- expected results due to the weaker market conditions.
FEMSA Sells Refrigeration and Foodservice Division to Mill Point
by Zacks Equity Research
FMX sells its refrigeration and food service operations to Mill Point Capital, aiming to enhance long-term value by focusing on core business areas.
Freshpet's Q3 Earnings Top Estimates, Sales Rise 26% Y/Y
by Zacks Equity Research
FRPT reaches a key milestone, marking its 25th consecutive quarter of more than 25% year-on-year net sales growth.
MED Q3 Earnings Beat, Revenues Fall on Customer Acquisition Challenges
by Zacks Equity Research
Medifast's Q3 results lower earnings and revenues, highlighting challenges in customer acquisition. Management issues soft guidance for the fourth quarter.
Diageo Stock Declines 8% in a Month: What Should Investors Do Next?
by Zacks Equity Research
DEO has been committed to strengthening its portfolio of brands and countering challenges like a cautious consumer market and retailer inventory adjustments.
Vital Farms Q3 Earnings on Horizon: Key Insights for VITL Investors
by Zacks Equity Research
Vital Farms is set to report strong Q3 results, fueled by expanded distribution, a growing farm network and new product lines catering to rising consumer demand.
MGP Ingredients Q3 Earnings Beat, Growth Strategies Set in Motion
by Zacks Equity Research
MGPI registers a year-over-year decline in sales and earnings for Q3. However, ongoing investments in the brand portfolio are expected to drive long-term growth.
AB InBev Q3 Earnings Beat Estimates, Organic Revenues Rise 2.1%
by Zacks Equity Research
BUD posts solid earnings results in third-quarter 2024. Organic revenues rise 2.1%, led by the ongoing premiumization and higher revenue per hectoliter.
Vital Farms (VITL) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the most recent trading session, Vital Farms (VITL) closed at $34.56, indicating a -0.35% shift from the previous trading day.
Monster Beverage Gears Up for Q3 Earnings: Here's What You Should Know
by Zacks Equity Research
MNST's third-quarter 2024 results are likely to reflect gains from strength in its energy drinks category and product launches.
Investors Heavily Search Vital Farms, Inc. (VITL): Here is What You Need to Know
by Zacks Equity Research
Vital Farms (VITL) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
CLX Q1 Earnings & Sales Beat Estimates, Raised FY25 View Drives Stock
by Zacks Equity Research
Clorox's Q1 results reflect a recovery from last year's cyberattack-related woes. Organic sales across all segments and margin expansion boost its performance.
Vital Farms (VITL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Vital Farms (VITL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FEMSA Q3 Earnings Decline Y/Y, Sales Improve on Segmental Growth
by Zacks Equity Research
FMX's Q3 results reflect revenue growth across all operating segments. Favorable currency effects from the depreciation of the Mexican Peso also aid the top line.
Clorox Gears Up for Q1 Earnings: Here's What You Should Know
by Zacks Equity Research
CLX's first-quarter fiscal 2025 results are likely to gain from pricing and cost-saving efforts. It aims at innovation and brand building.
Are Consumer Staples Stocks Lagging Unilever (UL) This Year?
by Zacks Equity Research
Here is how Unilever PLC (UL) and Vital Farms (VITL) have performed compared to their sector so far this year.
Vital Farms (VITL) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Vital Farms (VITL) closed at $35.32 in the latest trading session, marking a +1.57% move from the prior day.
Newell Earnings Meet Estimates in Q3, Core Sales Decline 1.7% Y/Y
by Zacks Equity Research
NWL reports a sales decline in third-quarter 2024, owing to a year-over-year core sales drop of 1.7%.
Boston Beer's Q3 Earnings Beat Estimates, EPS Guidance Narrowed
by Zacks Equity Research
SAM's Q3 results reflect earnings growth, but challenges with Truly Seltzer and softer near-term category trends prompt a lower 2024 forecast.
Keurig Q3 Earnings In Line With Estimates, Stock Down on Sales Miss
by Zacks Equity Research
KDP Q3 results reflect gains from sales growth in the International and U.S. Refreshment Beverages segments driven by growth in volume/mix.